CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Increase in workplace drug testing
4.1.2. Growth in the drug screening market
4.2. Market Restraints & Challenges
4.2.1. The emergence of alternative drug screening tests
4.3. Market Opportunities
4.3.1. Emerging economies and market consolidation
4.3.2. Increasing Point-Of-Care specimen validity testing and regulatory approvals for
rapid testing products
CHAPTER 5. GLOBAL SPECIMEN VALIDITY TESTING MARKET – BY PRODUCT
& SERVICE
5.1. Products
5.1.1. Reagents, Calibrators, and Controls
5.1.2. Assay Kits
5.1.3. Disposables
5.3. Services
CHAPTER 6. GLOBAL SPECIMEN VALIDITY TESTING MARKET – BY TYPE
6.1. Laboratory Testing
6.2. Rapid/PoC Testing
CHAPTER 7. GLOBAL SPECIMEN VALIDITY TESTING MARKET – BY END
USER
7.1. Workplaces
7.2. Drug Screening Laboratories
7.3. Criminal Justice and Law Enforcement Agencies
7.4. Pain Management Centers
7.5. Drug Rehabilitation Centers
7.6. Others
CHAPTER 8. GLOBAL SPECIMEN VALIDITY TESTING MARKET - BY
GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9. GLOBAL SPECIMEN VALIDITY TESTING MARKET - COMPANY
PROFILES
9.1. Laboratory Corporation
9.2. Quest Diagnostics Corporation
9.3. American Bio Medica Corporation
9.4. SciTec, Inc.
9.5. Premier Biotech, Inc.
9.6. Alfa Scientific Designs, Inc.
9.7. ACM Global Laboratories
9.8. Express Diagnostic International
9.9. Clinical Reference Laboratory
9.10. Thermo Fisher Scientific Company
9.11. Alere, Inc.
9.12. Sure Hire Service, Inc.
9.13. CannAmm Occupational Testing Services
CHAPTER 10. GLOBAL SPECIMEN VALIDITY TESTING MARKET -
COMPETITIVE LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11. MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12. APPENDIX
12.1. List of Tables
12.2. List of Figures
